This activity is expired and is no longer available for CME credit.


Drug Delivery Systems in Neovascular Retinal Disease

Author(s)/Faculty: Carl D. Regillo, MD, FACS; Charles C. Wykoff, MD, PhD
Release Date: 6/30/2020Expiration Date: 6/29/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: PodcastProvider:
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Charles Wykoff discuss emerging drug delivery systems for the management of neovascular retinal disease.